Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Acquisition costs

Share-based compensation

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Aurora Cannabis

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

NASDAQ | TSX: ACB EDMONTON, AB , April 24, 2023 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $22.3 million (US$16.6 million) principal amount of its convertible senior notes ("Notes") in multiple transactions since the start of April 2023 at a total cash cost, including accrued interest, of $16.7 million (US$12.4 million) and $5.3 million (US$4.0 million), including accrued interest, satisfied by the issuance of an aggregate ~6.35 million common shares of Aurora. In total, these transactions will save Aurora $2.6 million in annualized interest payments.

Aurora Repurchases ~$22 Million Principal Amount of Convertible Notes, Saving $1.2 Million in Annualized Interest Payments and Leaving ~$79 Million (US$59) of Notes Outstanding; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry

Canopy Growth

Cronos Group

Tilray Brands

The cannabis investment bonanza of 2021 may have come and gone, but there's still evidence that traders are bullish on the sector's upside, according to a report from New Frontier Data. In 2021, the cannabis industry saw more than $12 billion in investments, but in 2022 that figure was just $4 billion.

Cannabis investments shrunk in 2022, but less green didn't mean investors stopped finding value: report

Curaleaf Holdings, Inc.

SNDL Inc.

All three of these marijuana stocks have plunged; Aurora has been hit the hardest. Curaleaf is generating the highest operating cash flow of the group, but all remain unprofitable.

How Aurora Cannabis, Curaleaf, and SNDL Stack Up on 420 Day 2023

Tomorrow, 'only' in states where it's legal, cannabis will be celebrated as part of the long-fabled 4/20 (April 20) holiday.

4 Cannabis Stocks to Watch Right Now

WM Technology

OrganiGram Holdings Inc.

Scotts Miracle-Gro

Village Farms International

Here are seven steps to investing in the high-flying cannabis industry.

7 Steps to Investing in Marijuana Stocks

Electrameccanica

Tellurian

Penny stocks are enticing as they offer prospects of multibagger returns. High degree of speculation across penny stocks is another reason that makes it attractive for investors.

3 Penny Stocks to Sell Now While You Still Can

Novavax

Teladoc

Thanks to 13F filings, investors can follow what the brightest minds on Wall Street have been buying and selling. In spite of their poor performance, three beaten-down stocks were aggressively purchased by billionaire investors during the fourth quarter.

3 Former High-Flying Stocks Down 92% to 99% That Billionaire Investors Can't Stop Buying

Top Canadian Marijuana Stocks In The Cannabis Sector 2023 The post 2 Canadian Marijuana Stocks To Watch For This Weeks Trading appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Canadian Marijuana Stocks To Watch For This Weeks Trading

EDMONTON, AB, April 12, 2023 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and MedReleaf Australia today announced the launch of IndiMed Tempo 26, a range of new higher THC dried cannabis products for qualified patients under the MedReleaf Concession Scheme (MCS). Tempo 26 will add to the portfolio of products available, giving doctors the ability to prescribe from a wider range of options for medical cannabis patients.

Aurora and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients

A thriving black market and a glut of legal operators have weighed on profit margins in the Canadian cannabis space. This key pressure is likely to drive a wave of consolidation across the industry in the years to come.

Which Canadian Cannabis Company Will Be the Next Takeover Target?

The marijuana industry could see significant growth as legalization progresses in the U.S. and around the world. The risk for investors is that U.S. federal legalization isn't a certainty.

The Best Growth Stocks Could Be in This Industry -- but There's a Catch

Cannabis stocks have been in a major sell-off in the past few months as concerns about the industry remain. The closely-watched AdvisorShares Pure US Cannabis ETF (MSOS) was trading at $5.32 on Tuesday, its lowest level on record.

What happened to Cannabis stocks as their ETFs sink?

Green Thumb Industries Inc.

Global cannabis sales could grow 13% annually till 2026. Aurora Cannabis burned more cash than it generated in the last quarter.

Better Buy: Aurora Cannabis vs. Green Thumb Industries

The company could feel the pinch from higher oil prices via rising costs and lower consumer spending power. This dual threat is weighing on the cannabis company's shares today.

Why Aurora Cannabis Stock Is Slumping Today

While legal cannabis has not gone national yet, some cannabis companies hoping to up their brand profile by partnering with national brands.

Cannabis Companies Aren't Federally Legal — But Can Still Team Up With National Brands

Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) shares jumped after it revealed that it had repurchased C$46.6 million (US$34.3 million) of its convertible senior notes at a total cost including accrued interest of $45.6 million (US$33.6 million) in cash, saving $2.6 million in annualized interest payments. The Edmonton, Alberta-based cannabis company said that after the repurchase, it will have $103 million (US$76 million) of notes outstanding.

Aurora Cannabis stock jumps on move to save $2.6M annually

NASDAQ | TSX: ACB EDMONTON, AB , March 30, 2023 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $46.6 million (US$34.3 million) principal amount of its convertible senior notes ("Notes") at a total cost, including accrued interest, of $45.6 million (US$33.6 million) in cash, saving $2.6 million in annualized interest payments. Following completion of this repurchase, Aurora will have approximately $103 million (US$76 million) of Notes outstanding.

Aurora Repurchases ~$47 Million Principal Amount of Convertible Notes, Saving $2.6 Million in Annualized Interest Payments; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry

Aurora Cannabis has focused more on medical marijuana over the years, but that hasn't resulted in profitability. Its gross margin is too small to cover the company's overhead and operating expenses.

Don't Buy the Hype: Aurora Cannabis' Transformation Hasn't Worked

Aurora reached its goal last quarter of positive adjusted EBITDA. The company sells cannabis in 11 countries.

2 Reasons to Buy Aurora Cannabis and 1 Reason to Sell It

Marijuana stock investors are keeping focused on the future of the sector. Specifically, most cannabis stock investors are setting a plan that will prepare them for when more consistent trading will take place.

Marijuana Stocks To Buy The All Of April 2023?

HEXO Corp

High Tide

Jazz Pharmaceuticals

Trulieve Cannabis Corp.

This developing industry has ample opportunity and sustained tailwinds. Very few U.S. companies have positive operating margins; very few of their Canadian counterparts have positive gross margins.

Finding The Long-Term Winners In The Cannabis Sector

NASDAQ | TSX: ACB EDMONTON, AB , March 24, 2023 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced receipt of a notification letter (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") dated March 24, 2023, advising that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1) as the bid price of the Company's listed securities had closed at less than US$1.00 per share over the last 30 consecutive business days (the "Minimum Bid Price Requirement") from February 8, 2023 to March 23, 2023. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has until September 20, 2023, being 180 calendar days from the date of the Notification Letter (the "Compliance Period"), to regain compliance with the Minimum Bid Price Requirement.

Aurora Provides Update on Nasdaq Listing

Coinbase

MicroStrategy Incorporated

Among the groups of Nasdaq stocks in trouble this year are crypto names and marijuana stocks. When it comes to cryptos, Washington is clearly attacking the sector.

3 Nasdaq Stocks Facing Regulatory Hot Water in 2023

Best Canadian Pot Stocks For April? The post Canadian Marijuana Stocks To Buy: 3 Penny Stocks On Watch For April appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks To Buy: 3 Penny Stocks On Watch For April

Marijuana stocks have been incurring big losses over the past few years, and it could be a while before their fortunes turn around. The one big catalyst that could change things is marijuana legalization.

News for Aurora Cannabis Stock (ACB)